• 1. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Hydroxy acids and derivatives Beta hydroxy acids and derivatives

Professional Introduction to Racemic 3-Hydroxyisobutyric Acid (CAS No. 2068-83-9)

Racemic 3-Hydroxyisobutyric Acid (CAS No. 2068-83-9) is a significant compound in the field of chemical and pharmaceutical research, characterized by its unique molecular structure and versatile biological activities. This compound, also known as racemic 3-hydroxy-2-methylpropanoic acid, has garnered considerable attention due to its potential applications in drug development, metabolic studies, and biochemical pathways. The racemic form indicates that it is a mixture of equal amounts of two enantiomers, which can exhibit different biological properties depending on the context of use.

The chemical structure of Racemic 3-Hydroxyisobutyric Acid consists of a hydroxyl group attached to a methyl-substituted isobutyric acid backbone. This configuration makes it an interesting subject for researchers exploring enzyme mechanisms, metabolic intermediates, and synthetic pathways. The compound's ability to participate in various biochemical reactions has led to its investigation in both in vitro and in vivo models. Recent studies have highlighted its role in understanding the metabolism of branched-chain amino acids, which are crucial for energy production and protein synthesis in living organisms.

In the realm of pharmaceutical research, Racemic 3-Hydroxyisobutyric Acid has been studied for its potential as a precursor or intermediate in the synthesis of more complex molecules. Its structural simplicity allows for modifications that can lead to novel compounds with therapeutic properties. For instance, derivatives of this acid have been explored for their anti-inflammatory and analgesic effects. The racemic nature of the compound necessitates further research to determine if one enantiomer is more active or if both forms contribute to its overall biological activity.

Recent advancements in analytical chemistry have enabled more precise characterization of Racemic 3-Hydroxyisobutyric Acid. Techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have provided insights into its purity, enantiomeric excess, and interaction with biological targets. These methods are crucial for ensuring that the compound meets the stringent standards required for pharmaceutical applications. Additionally, computational modeling has been employed to predict how this compound might behave within complex biological systems, aiding in the design of targeted experiments.

The biological significance of 3-Hydroxyisobutyric Acid extends beyond its role as a metabolic intermediate. Studies have shown that it can influence various signaling pathways, making it a candidate for therapeutic intervention in diseases associated with metabolic dysregulation. For example, research has suggested that this compound may play a role in energy homeostasis and insulin sensitivity. By understanding its mechanisms of action, scientists can develop strategies to leverage its properties for treating conditions such as diabetes and obesity.

The synthesis of Racemic 3-Hydroxyisobutyric Acid presents both challenges and opportunities for chemists. Traditional synthetic routes often involve multi-step processes that require careful optimization to achieve high yields and purity. However, recent innovations in green chemistry have led to more sustainable methods for producing this compound. These approaches focus on reducing waste and minimizing the use of hazardous reagents, aligning with the growing emphasis on environmentally friendly practices in pharmaceutical manufacturing.

In conclusion, Racemic 3-Hydroxyisobutyric Acid (CAS No. 2068-83-9) is a multifaceted compound with significant implications for chemical biology and drug development. Its unique structure and biological activities make it a valuable tool for researchers investigating metabolic pathways, enzyme function, and therapeutic interventions. As our understanding of this compound continues to evolve, it is likely to remain at the forefront of scientific inquiry, contributing to advancements in medicine and biotechnology.

• 595-46-0(dimethylpropanedioic acid)
• 2831-90-5(tris(hydroxymethyl)acetic acid)
• 42522-59-8(Methylmalonic Acid-d3)
• 4767-03-7(2,2-Bis(hydroxymethyl)propionic acid)
• 4835-90-9(3-Hydroxypivalic Acid)
• 516-05-2(Methylmalonic Acid)
• 1910-47-0((2R)-3-hydroxy-2-methylpropanoic acid)
• 56974-57-3(Propanoic acid,3-hydroxy-2,2-dimethyl-, sodium salt (1:1))
• 26543-05-5((S)-3-Hydroxy-2-methylpropanoic acid)
• 53007-37-7(Propanedioic acid, 2-Methyl-, disodiuM salt)